| 
 | 
 | 
 | Attachment Cb. State and County Representative Data Collection Instrument | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | XDR TB Contact Investigation: A Cost Assessment | 
 | Form Approved | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Costs to state health departments | 
 | OMB No. 0920-0879 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | Expiration Date 03/31/2018 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Preparation for the contact investigation and initial assessments of each contact | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Today's date | 1/26/2021 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Date that data provided to the CDC represents as endpoint of data collection | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 1 | Location and collaborator information | Name | Job title | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 0 | 1 | 
 | State | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 0 | 2 | 
 | Who reported the data collected in this sheet? | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 2 | Contact investigation outcomes | Number | Notes | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 3 | 
 | Total number of hours identifying contacts in your state | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 4 | 
 | Total number of contacts identified in your state | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 5 | 
 | Number of high priority contacts or 'close contacts' | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 6 | 
 | Number of medium priority contacts | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 7 | 
 | Number of low priority contacts or 'casual contacts' | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 8 | 
 | Total number of contacts evaluated for TB in your state | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 1 | 9 | 
 | How confident are you that this represents the total number of actual contacts? | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 3 | Tests and results for TB infection and disease | Administered | # positive | # negative | # indeterminate | Notes | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Tuberculin skin testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 10 | 
 | Number of tuberculin skin test (TST) placements with TB education | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 11 | 
 | Number of TST test readings | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | IGRA testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 12 | 
 | Number of QuantiFERON Gold In-tube (QFT-GIT) IGRA tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 13 | 
 | Number of T-spot IGRA tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Testing for TB disease | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 14 | 
 | Number of physical examinations | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 15 | 
 | Number of chest x-rays (CXR) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 16 | 
 | Number of sputum inductions | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 17 | 
 | Number of smear microscopy and culture tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 18 | 
 | Number of nucleic acid amplification (NAA) tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 4 | Risk factors for developing TB disease after infection | Number | Notes | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Number of contacts who were born in any of the following regions | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 19 | 
 | Africa | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 20 | 
 | Asia | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 21 | 
 | Pacific Islands | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 22 | 
 | Central America | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 23 | 
 | South America | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 24 | 
 | Mexico | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 25 | 
 | Eastern Europe | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 26 | 
 | Caribbean | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 27 | 
 | Middle East | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 28 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Number of contacts who have lived or travelled in any of the following regions for more than one month | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 29 | 
 | Africa | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 30 | 
 | Asia | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 31 | 
 | Pacific Islands | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 32 | 
 | Central America | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 33 | 
 | South America | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 34 | 
 | Mexico | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 35 | 
 | Eastern Europe | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 36 | 
 | Caribbean | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 37 | 
 | Middle East | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 38 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Medical risk factors | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 39 | 
 | Number of contacts with a history of LTBI | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 40 | 
 | Number of contacts with a history of TB disease | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 41 | 
 | Number of contacts that had received the BCG vaccine | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 42 | 
 | Number of contacts with diabetes | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 43 | 
 | Number of contacts with HIV/AIDS | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 44 | 
 | Number of contacts with autoimmune disease or other immunosuppressive condition | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 45 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Non medical risk factors | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 46 | 
 | Number of contacts that were close contacts of someone with TB disease other than the index case | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 47 | 
 | Number of contacts under 5 years old | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 48 | 
 | Number of contacts that have been a resident of a correctional facility in the past year | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 49 | 
 | Number of contacts that have ever used injection drugs | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 50 | 
 | Number of contacts that were homeless in the past year | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 51 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 5 | Cost of testing for TB infection and disease | Cost per service | Who paid for it | Notes | For checking | 
 | 
 | 
 | 
 | 
	
		| 3 | 52 | 
 | Tuberculin Skin Tests (TST) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 53 | 
 | Quantiferon Gold In Tube (QFT-GIT) IGRAs | 
 | 
 | 
 | no | 
 | 
 | 
 | 
 | 
	
		| 3 | 54 | 
 | T-spot IGRAs | 
 | 
 | 
 | no | 
 | 
 | 
 | 
 | 
	
		| 3 | 55 | 
 | Physical examinations | 
 | 
 | 
 | no | 
 | 
 | 
 | 
 | 
	
		| 3 | 56 | 
 | Chest X-rays (CXR) | 
 | 
 | 
 | no | 
 | 
 | 
 | 
 | 
	
		| 3 | 57 | 
 | Sputum inductions | 
 | 
 | 
 | no | 
 | 
 | 
 | 
 | 
	
		| 3 | 58 | 
 | Sputum smear and cultures | 
 | 
 | 
 | no | 
 | 
 | 
 | 
 | 
	
		| 3 | 59 | 
 | Nucleic acid amplification (NAA) tests | 
 | 
 | 
 | no | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 6 | Cost of testing for other illnesses that are risk factors for TB disease | Number of services provided | Cost per service | Who paid for it | Notes | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | HIV testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 60 | 
 | ELISA | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 61 | 
 | Western blot | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 62 | 
 | Rapid diagnostic test | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Diabetes testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 63 | 
 | Hemoglobin A1C test | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 64 | 
 | Blood glucose test | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Kidney disease testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 65 | 
 | Urinalysis | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 66 | 
 | Ultrasound | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 67 | 
 | Computerized tomography | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 68 | 
 | Biopsy | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Any other test | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 69 | 
 | please indicate | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 7 | Cost of LTBI treatment | Number of regimens initiated | Cost per dose | Doses taken | Who paid for it | Notes | 
 | 
 | 
 | 
	
		| 5 | 70 | 
 | 6H Isoniazid (INH) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 71 | 
 | 9H Isoniazid (INH) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 72 | 
 | 4R Rifampin (RIF) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 73 | 
 | 3HT Isoniazid (INH) Rifapentine (RPT) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 74 | 
 | Cycloserine (CYC) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 8 | Personnel costs | Number of personnel | Total hours spent on XDR contact investigation | Gross Annual Salary without benefits 
 | Percent fringe benefit | Who paid for it | Notes | 
 | 
 | 
	
		| 
 | 
 | 
 | Investigative personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 75 | 
 | Outreach workers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 76 | 
 | Nurse consultants | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 77 | 
 | Statisticians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 78 | 
 | Epidemiologists | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 79 | 
 | Translators | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Health care providers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 80 | 
 | Nursing supervisors | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 81 | 
 | Nurses | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 82 | 
 | Physicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 83 | 
 | Counsellors | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 84 | 
 | Social workers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 85 | 
 | Volunteers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Administrative personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 86 | 
 | Program managers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 87 | 
 | Administative clerks | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 88 | 
 | Health information technicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 89 | 
 | Receptionists | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 90 | 
 | File clerks | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Laboratory personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 91 | 
 | Lab technicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 92 | 
 | Radiology technicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | State Department of Health and TB Controllers Office | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 93 | 
 | Director | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 94 | 
 | Assistant director | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 95 | 
 | Chief of staff | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 96 | 
 | Infectious diseases chief | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 97 | 
 | Infectious diseases deputy | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 97 | 
 | TB controller | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 98 | 
 | Chief nurse consultant | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 99 | 
 | Communications officers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 100 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Other personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 101 | 
 | Please indicate | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Check | 0 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 9 | Travel costs | Total units used or consumed | Total amount spent | Who paid for it | Notes | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Vehicle Use (miles) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 102 | 
 | Vehicle 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 103 | 
 | Vehicle 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 104 | 
 | Per diem | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 105 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 10 | Training costs | Total number of each personnel category receiving training | Number of personnel receiving training who were involved in the contact investigation or support | Cost per training course | Duration of the training validity | Proportion dedicated to the XDR contact investigation | Who provided the training? (external, or in-house) | Who paid for it | Notes | 
	
		| 
 | 
 | 
 | Training 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 106 | 
 | Participant personnel category 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 107 | 
 | Participant personnel category 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Training 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 108 | 
 | Participant personnel category 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 109 | 
 | Participant personnel category 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 11 | Costs of incentives and enablers | Units consumed | Cost per item | Who paid for it | Notes | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Incentives to come to health center | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 110 | 
 | Please list | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Enablers to come to health center | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 111 | 
 | Please list | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 12 | Any other miscellaneous costs | Units consumed | Cost per unit | Percent dedicated to XDR contact investigation | Who paid for it | Notes | 
 | 
 | 
 | 
	
		| 5 | 112 | 
 | Please indicate | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 464 | Total blanks on this page | 
 | CDC estimates the average public reporting burden for this collection of information as 2 hours (1.5 hours for the program manager, and 30 minutes for the accountant | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | including the time for reviewing instructions, searching existing data/information sources, | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 807 | Total blanks on spreadsheet | 
 | gathering and maintaining the data/information needed, and completing and reviewing the collection of information. | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | An agency may not conduct or sponsor, and a person is not required to respond to a collection of information | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | unless it displays a currently valid OMB control number. Send comments regarding this burden estimate | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | or any other aspect of this collection of information, including suggestions for reducing burden to CDC/ATSDR | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Information Collection Review Office, | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0879). | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
	
	
	
	
	
	
	
	
	
	
		| 
 | 
 | 
 | Costs to state health departments | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Estimated cost of investigating and following contacts of an extensively drug resistant patient in the United States | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Follow-up period to this point | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 13 | Tests and results for TB infection and disease | Administered | # positive | # negative | # indeterminate | Notes | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Tuberculin skin testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 113 | 
 | Number of tuberculin skin test (TST) placements with TB education | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 114 | 
 | Number of TST test readings | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | IGRA testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 115 | 
 | Number of QuantiFERON Gold In-tube (QFT-GIT) IGRA tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 116 | 
 | Number of T-spot IGRA tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Testing for TB disease | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 117 | 
 | Number of physical examinations | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 118 | 
 | Number of chest x-rays (CXR) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 2 | 119 | 
 | Number of sputum inductions | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 120 | 
 | Number of smear microscopy and culture tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 5 | 121 | 
 | Number of nucleic acid amplification (NAA) tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 14 | Cost of testing for TB infection and disease | Cost per service | Who paid for it | Notes | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Tuberculin skin testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 122 | 
 | Number of tuberculin skin test (TST) placements with TB education | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 123 | 
 | Number of TST test readings | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | IGRA testing | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 124 | 
 | Number of QuantiFERON Gold In-tube (QFT-GIT) IGRA tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 125 | 
 | Number of T-spot IGRA tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Testing for TB disease | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 126 | 
 | Physical examinations | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 127 | 
 | Chest X-rays (CXR) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 128 | 
 | Sputum inductions | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 129 | 
 | Sputum smear and culture tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 3 | 130 | 
 | Nucleic acid amplification (NAA) tests | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 15 | Cost of LTBI treatment | Cost per dose | Doses taken | Who paid for it | Notes | 
 | 
 | 
 | 
 | 
	
		| 4 | 131 | 
 | 6H Isoniazid (INH) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 132 | 
 | 9H Isoniazid (INH) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 133 | 
 | 4R Rifampin (RIF) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 134 | 
 | 3HT Isoniazid (INH) Rifapentine (RPT) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 135 | 
 | Cycloserine (CYC) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 16 | Personnel costs | Number of personnel | Total hours spent on XDR contact investigation | Gross Annual Salary without benefits 
 | Percent fringe benefit | Who paid for it | Notes | 
 | 
 | 
	
		| 
 | 
 | 
 | Investigative personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 136 | 
 | Outreach workers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 137 | 
 | Nurse consultants | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 138 | 
 | Statistician | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 139 | 
 | Epidemiologist | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 140 | 
 | Translators | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Health care providers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 141 | 
 | Nursing supervisors | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 142 | 
 | Nurses | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 143 | 
 | Physicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 144 | 
 | Counsellors | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 145 | 
 | Social workers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 146 | 
 | Volunteers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Administrative personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 147 | 
 | Program managers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 148 | 
 | Administative clerk | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 149 | 
 | Health information technicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 150 | 
 | Receptionists | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 151 | 
 | File clerks | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Laboratory personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 152 | 
 | Lab technicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 153 | 
 | Radiology technicians | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | State Department of Health and TB Controllers Office | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 154 | 
 | Director | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 155 | 
 | Assistant director | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 156 | 
 | Chief of staff | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 157 | 
 | Infectious diseases chief | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 158 | 
 | Infectious diseases deputy | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 159 | 
 | TB controller | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 160 | 
 | Chief nurse consultant | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 161 | 
 | Communications officers | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 162 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Other personnel | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 7 | 163 | 
 | Please indicate | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Check | 0 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 17 | Travel costs | Total units used or consumed | Total amount spent | Who paid for it | Notes | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Vehicle Use (miles) | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 164 | 
 | Vehicle 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 165 | 
 | Vehicle 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 166 | 
 | Per diem | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 167 | 
 | Other | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 18 | Training costs | Total number of each personnel category receiving training | Number of personnel receiving training who were involved in the contact investigation or support | Cost per training | Duration of the training validity | Proportion dedicated to the XDR contact investigation | Who provided the training | Who paid for it | Notes | 
	
		| 
 | 
 | 
 | Training 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 168 | 
 | Participant personnel category 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 169 | 
 | Participant personnel category 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Training 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 170 | 
 | Participant personnel category 1 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 8 | 171 | 
 | Participant personnel category 2 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | etc | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 19 | Costs of incentives and enablers | Units consumed | Cost per item | Who paid for it | Notes | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Incentives to come to health center | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 172 | 
 | Please list | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | Enablers to come to health center | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 4 | 173 | 
 | Please list | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 20 | Any other miscellaneous costs | Units consumed | Cost per unit | Percent dedicated to XDR contact investigation | Who paid for it | Notes | 
 | 
 | 
 | 
	
		| 5 | 174 | 
 | Please indicate | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
	
		| 343 | Total blanks on this page | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 |